Literature DB >> 1736576

Hypotension during dobutamine stress echocardiography: initial description and clinical relevance.

T L Rosamond1, J L Vacek, A Hurwitz, A J Rowland, G D Beauchamp, L J Crouse.   

Abstract

Hypotension during exercise treadmill testing is correlated with the presence of coronary artery disease, its severity, and prognosis. The importance of hypotension during dobutamine stress testing has not been previously reported to our knowledge. We reviewed 43 cases of hypotension occurring in 42 patients out of a total of 116 consecutive stress dobutamine echocardiographic procedures performed in a total of 112 patients. Of the 42 patients with hypotension, 20 underwent cardiac catheterization. Regional wall motion abnormalities induced by dobutamine infusion were found in 13 of these patients, all of whom had significant (greater than or equal to 70% diameter reduction) coronary artery disease. The remaining seven patients without regional wall motion abnormalities did not have significant coronary artery disease at catheterization. Of the remaining 22 patients with dobutamine-induced hypotension, 20 had no induced regional wall motion abnormalities, were not catheterized, and were followed clinically. None of these patients had a cardiac event during a mean follow-up period of 11.5 months. We conclude that hypotension during dobutamine stress echocardiography in the absence of regional wall motion abnormalities does not indicate significant coronary artery disease or portend an adverse prognosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736576     DOI: 10.1016/0002-8703(92)90652-c

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Safety and cardiac chronotropic responsiveness to the early injection of atropine during dobutamine stress echocardiography in the elderly.

Authors:  J M Tsutsui; F Cerqueira Lario; D R Fernandes; I Kowatsch; J C Sbano; J A Franchini Ramires; W Mathias
Journal:  Heart       Date:  2005-03-29       Impact factor: 5.994

2.  Frequency, Predictors, and Implications of Abnormal Blood Pressure Responses During Dobutamine Stress Echocardiography.

Authors:  Sara Abram; Adelaide M Arruda-Olson; Christopher G Scott; Patricia A Pellikka; Vuyisile T Nkomo; Jae K Oh; Alberto Milan; Mohamed M Abidian; Robert B McCully
Journal:  Circ Cardiovasc Imaging       Date:  2017-04       Impact factor: 7.792

3.  Do beta-blockers affect the diagnostic sensitivity of dobutamine stress thallium-201 single photon emission computed tomographic imaging?

Authors:  P J Huang; R F Yen; P U Chieng; M L Chen; C T Su
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

4.  Typical blood pressure response during dobutamine stress echocardiography of patients without known cardiovascular disease who have normal stress echocardiograms.

Authors:  Sara Abram; Adelaide M Arruda-Olson; Christopher G Scott; Patricia A Pellikka; Vuyisile T Nkomo; Jae K Oh; Alberto Milan; Robert B McCully
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-07-22       Impact factor: 6.875

5.  Cardiovascular effects of dobutamine stress testing in women with suspected coronary artery disease.

Authors:  P Blomstrand; J Engvall; E Swahn; K Säfström; O Thulesius; B Wranne
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 6.  Dobutamine stress echocardiography in clinical practice with a review of the recent literature.

Authors:  E Barasch; S Wilansky
Journal:  Tex Heart Inst J       Date:  1994
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.